Sparsentan Provides Better Proteinuria Reduction in FSGS ...Middle East

A post-hoc analysis of the DUPLEX trial shows significantly greater improvements in proteinuria-related outcomes vs irbesartan for tough-to-treat FSGS. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Sparsentan Provides Better Proteinuria Reduction in FSGS )

Also on site :

• Opinion: Tolerance of diversity is central to San Diego’s economic growth
• ‘Deeply concerned’ over India press censorship, says X as accounts blocked
• Doctor accused of abusing patients treated California hospital like a ‘sexual playground,’ attorneys allege